000 01532 a2200361 4500
005 20250514205821.0
264 0 _c20050329
008 200503s 0 0 eng d
022 _a0147-8389
024 7 _a10.1111/j.1540-8159.2004.00645.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMadrid, Antonio H
245 0 0 _aThe role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials.
_h[electronic resource]
260 _bPacing and clinical electrophysiology : PACE
_cOct 2004
300 _a1405-10 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis
650 0 4 _aAngiotensin II Type 1 Receptor Blockers
_xtherapeutic use
650 0 4 _aAngiotensin-Converting Enzyme Inhibitors
_xtherapeutic use
650 0 4 _aAtrial Fibrillation
_xetiology
650 0 4 _aCardiovascular Diseases
_xcomplications
650 0 4 _aHumans
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aPeng, Jian
700 1 _aZamora, Javier
700 1 _aMarín, Irene
700 1 _aBernal, Enrique
700 1 _aEscobar, Carlos
700 1 _aMuños-Tinoco, Concepción
700 1 _aRebollo, José M G
700 1 _aMoro, Concepción
773 0 _tPacing and clinical electrophysiology : PACE
_gvol. 27
_gno. 10
_gp. 1405-10
856 4 0 _uhttps://doi.org/10.1111/j.1540-8159.2004.00645.x
_zAvailable from publisher's website
999 _c15200098
_d15200098